Back on Tip TV talking about Brexit's impact on UK M&A, Wirecard and BioMarin

Here's is a link to today's session on Tip TV with the erudite Zak Mir.

https://www.youtube.com/watch?v=PaqcAMy-fek

Sanofi said to weigh alternative deals to Medivation; eyes BioMarin Pharmaceutical - sources

French pharmaceutical giant Sanofi is working on a back up plan in case it fails to win its $9.3 billion hostile pursuit of US-listed Medivation.

Top sources have told me the French pharmaceutical giant has begun looking at US-based rare disease specialist BioMarin Pharmaceutical as a potential alternative takeover deal after growing frustrated in its pursuit of Medivation, which has so far resisted the French company's advances.

RARE alert: Shire's next deal could be "transformational" - part 2

This (see below) well written interview with Shire chief executive Flemming Ornskov by the Wall Street Journal would appear to reinforce the idea that the FTSE 100-listed group is still on the hunt for a major acquisition - whether it be Actelion, BioMarin or another (US?) rival...

http://www.wsj.com/articles/shire-deepens-push-into-biotech-after-abbvie-drops-bid-1436821429?mod=pls_whats_news_us_business_f&utm_source=dlvr.it&utm_medium=twitter

Back on Tip TV talking about chip deals, the WSJ and Pfizer/Cellectis/BioMarin

Apologies for the tardy posting - I have been out all day looking for jackanories.

Anyway, here is today's Tip TV clip with the my pal Nick "Moose" Batsford.

Back on Tip TV talking about Quindell, BP, BioMarin and Sky

Zak invited back onto Tip TV today. Here is a link to today's session:

http://www.tiptv.co.uk/archives/weekly-ma-update/

Back on Tip TV talking about Quindell, SAB Miller, BioMarin and Shire

There was plenty of backslapping (well, by myself at least) during my Tip TV slot this morning. Here is a link to today's clip: http://www.tiptv.co.uk/archives/mergers-and-acquisitions-4/

RARE alert: Shire said to be weighing "transformational" $65 billion merger with BioMarin Pharmaceutical

Perhaps I spoke (or wrote) to soon about Shire's next "transformational" deal taking a while to happen - see the link: http://betaville123.blogspot.co.uk/2015/03/rare-alert-shires-next-deal-likely-to.html.

Top sources (and I mean top) tell me FTSE 100-listed Shire has set it sights on combining with BioMarin Pharmaceutical, a US-listed company that specialises in making therapies for people with extremely rare genetic diseases.